- Type / Class
- Equity / Common Stock
- Shares outstanding
- 80,855,533
- Total 13F shares
- 78,779,105
- Share change
- +1,101,924
- Total reported value
- $4,025,030,193
- Put/Call ratio
- 70%
- Price per share
- $50.96
- Number of holders
- 260
- Value change
- +$67,568,904
- Number of buys
- 133
- Number of sells
- 117
Quarterly Holders Quick Answers
What is CUSIP 69366J200?
CUSIP 69366J200 identifies PTCT - PTC THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 69366J200:
Top shareholders of PTCT - PTC THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
9,178,822
|
$414,332,026 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
9.8%
|
7,898,801
|
$356,551,878 | — | 31 Dec 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
9.1%
|
7,393,127
|
$333,725,753 | — | 31 Dec 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
6.9%
from 13D/G
|
6,378,000
|
$287,902,920 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.9%
|
4,787,123
|
$216,090,731 | — | 31 Dec 2024 | |
| Camber Capital Management LP |
13D/G
13F
|
Company |
4.2%
|
3,200,000
|
$158,464,000 | $0 | 31 Dec 2024 | |
| TORONTO DOMINION BANK |
13F
|
Company |
4.1%
|
3,286,729
|
$148,362,947 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.3%
|
2,707,996
|
$122,238,939 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.9%
|
2,325,915
|
$105,015,067 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
1,797,016
|
$81,136,652 | — | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.9%
|
1,542,292
|
$69,619,061 | — | 31 Dec 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.8%
|
1,443,362
|
$65,153,361 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.6%
|
1,278,188
|
$57,697,406 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.3%
|
1,077,794
|
$48,651,621 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
1,073,817
|
$48,472,122 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
1.3%
|
1,071,051
|
$48,347,243 | — | 31 Dec 2024 | |
| Blackstone Inc. |
13F
|
Company |
1.3%
|
1,059,574
|
$47,829,170 | — | 31 Dec 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,041,059
|
$46,993,403 | — | 31 Dec 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1%
|
826,519
|
$37,309,068 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
1%
|
820,044
|
$37,016,787 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.95%
|
764,625
|
$34,515,172 | — | 31 Dec 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.91%
|
736,388
|
$33,240,554 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.9%
|
727,976
|
$32,860,836 | — | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.87%
|
700,000
|
$31,598,000 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.85%
|
685,709
|
$30,952,904 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.81%
|
653,100
|
$29,480,934 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.8%
|
649,269
|
$29,308,004 | — | 31 Dec 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.72%
|
584,326
|
$26,377,000 | — | 31 Dec 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
568,364
|
$25,655,951 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.63%
|
509,204
|
$22,987,000 | — | 31 Dec 2024 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.61%
|
492,420
|
$22,227,839 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.57%
|
458,015
|
$20,674,797 | — | 31 Dec 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.54%
|
439,670
|
$19,846,704 | — | 31 Dec 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.54%
|
434,767
|
$19,625,382 | — | 31 Dec 2024 | |
| Palo Alto Investors LP |
13F
|
Company |
0.48%
|
386,413
|
$17,442,683 | — | 31 Dec 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.45%
|
361,644
|
$16,324,610 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.45%
|
360,442
|
$16,270,352 | — | 31 Dec 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.39%
|
313,417
|
$14,147,643 | — | 31 Dec 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.39%
|
312,016
|
$14,084,402 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.38%
|
309,423
|
$13,967,354 | — | 31 Dec 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.38%
|
306,756
|
$13,846,966 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.32%
|
256,536
|
$11,580,035 | — | 31 Dec 2024 | |
| Stuart Walter Peltz |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
399,365
mixed-class rows
|
$10,876,127 | — | 31 Jan 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.28%
|
230,131
|
$10,388,113 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
216,882
|
$9,790,045 | — | 31 Dec 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.26%
|
208,302
|
$9,402,753 | — | 31 Dec 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.24%
|
192,481
|
$8,688,592 | — | 31 Dec 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.22%
|
177,368
|
$8,006,392 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.21%
|
173,352
|
$7,825,109 | — | 31 Dec 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.21%
|
170,697
|
$7,705,301 | — | 31 Dec 2024 |
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2025
As of 31 Mar 2025,
PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by
260 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,779,105 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., RTW INVESTMENTS, LP, ARMISTICE CAPITAL, LLC, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, TORONTO DOMINION BANK, STATE STREET CORP, FMR LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
259
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
237
Q1 2025 holders
260
Holder diff
23
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.